AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 20-A-07-162.04
We recommend that the Maine Department of Health and Human Services consider invoicing drug manufacturers for rebates totaling $10.8 million…
The recommendation, in the publisher's words
We recommend that the Maine Department of Health and Human Services consider invoicing drug manufacturers for rebates totaling $10.8 million (Federal share) for claims for physician-administered drugs dispensed at non-Critical Access Hospitals.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- September 14, 2020
- Report
- Maine Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs (A-07-18-06079) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- March 10, 2023 (publisher's date)
- Potential savings
- $10,801,067 (the publisher's figure; not realised savings)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Unimplemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
4 more, of which 0 are open in the publisher's file.
- We recommend that the Maine Department of Health and Human Services refund to the Federal Government $4,004,984 (Federal share) for claims for single-source physician-administered drugs…HHS OIG 20-A-07-162.01 · issued Sep 14, 2020 · closed Mar 10, 2023Closed Acceptable Alternative
- We recommend that the Maine Department of Health and Human Services refund to the Federal Government $276,229 (Federal share) for claims for top-20 multiple-source physician-administered…HHS OIG 20-A-07-162.02 · issued Sep 14, 2020 · closed Mar 10, 2023Closed Acceptable Alternative
- We recommend that the Maine Department of Health and Human Services work with CMS to determine the unallowable portion of $605,768 (Federal share) for other claims for multiple-source…HHS OIG 20-A-07-162.03 · issued Sep 14, 2020 · closed Nov 16, 2020Closed Implemented
- We recommend that the Maine Department of Health and Human Services strengthen its internal controls to ensure that all physician-administered drugs eligible for rebates are invoiced.HHS OIG 20-A-07-162.05 · issued Sep 14, 2020 · closed Nov 16, 2020Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.